Nicholas Investment Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-115,092
Closed -$4.53M 185
2022
Q2
$4.53M Hold
115,092
0.43% 86
2022
Q1
$8.05M Buy
115,092
+9,514
+9% +$695K 0.57% 59
2021
Q4
$8.22M Sell
105,578
-12,681
-11% -$1.12M 0.52% 75
2021
Q3
$11.3M Sell
118,259
-54,909
-32% -$5.8M 0.82% 47
2021
Q2
$21.5M Buy
173,168
+4,884
+3% +$583K 1.35% 14
2021
Q1
$22.2M Buy
168,284
+16,538
+11% +$2.26M 1.55% 11
2020
Q4
$20.1M Buy
151,746
+234
+0.2% +$28.3K 1.55% 17
2020
Q3
$15.4M Buy
151,512
+130,243
+612% +$11.2M 1.67% 17
2020
Q2
$1.85M Sell
21,269
-15,449
-42% -$1.23M 0.38% 102
2020
Q1
$2.13M Sell
36,718
-38,260
-51% -$3.11M 0.41% 100
2019
Q4
$6.93M Sell
74,978
-14,910
-17% -$1.31M 0.71% 31
2019
Q3
$8.12M Buy
89,888
+8,535
+10% +$972K 0.68% 36
2019
Q2
$9.6M Sell
81,353
-2,862
-3% -$288K 0.88% 24
2019
Q1
$7.29M Sell
84,215
-62,461
-43% -$5.32M 0.65% 30
2018
Q4
$9.26M Sell
146,676
-11,960
-8% -$821K 1% 13
2018
Q3
$12.5M Buy
158,636
+32,084
+25% +$2.09M 1% 13
2018
Q2
$7.57M Buy
126,552
+21,829
+21% +$1.17M 0.53% 44
2018
Q1
$4.22M Sell
104,723
-103,183
-50% -$5.03M 0.3% 108
2017
Q4
$10.9M Sell
207,906
-31,067
-13% -$1.66M 0.72% 17
2017
Q3
$11.3M Buy
238,973
+93,164
+64% +$3.75M 0.78% 12
2017
Q2
$5.16M Sell
145,809
-10,767
-7% -$332K 0.36% 80
2017
Q1
$3.7M Buy
+156,576
New +$3.1M 0.26% 134
2014
Q1
Sell
-138,320
Closed -$1.63M 297
2013
Q4
$1.63M Buy
+138,320
New +$1.59M 0.12% 257
2013
Q3
Sell
-178,412
Closed -$2.48M 300
2013
Q2
$2.48M Buy
+178,412
New +$1.94M 0.23% 130

Other funds holding EXAS

Nicholas Investment Partners's EXAS Position: Q3 2022 in Review

Nicholas Investment Partners sold out of Exact Sciences (EXAS) in Q3 2022, closing a stake of 115,092 shares — an estimated $4.53M sold.

Nicholas Investment Partners first reported a position in EXAS in Q2 2013 and held it in 24 quarters. The position peaked at $22.2M in Q1 2021. 480 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

  • Nicholas Investment Partners reported no remaining Exact Sciences position as of Q3 2022 after selling out during the quarter.
  • Nicholas Investment Partners sold 115,092 Exact Sciences shares in Q3 2022, an estimated $4.53M.
  • Nicholas Investment Partners first reported a position in Exact Sciences in Q2 2013 and held it in 24 quarters.
  • Nicholas Investment Partners's Exact Sciences position peaked at $22.2M in Q1 2021.
  • 480 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on Nicholas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.